You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • FRI0010 Pharmacokinetics, Safety and Tolerance of BCD-085, A Novel IL-17 Inhibitor, Based on The Results of Phase 1 Clinical Study in Healthy Volunteers

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Cytokines and inflammatory mediators
FRI0010 Pharmacokinetics, Safety and Tolerance of BCD-085, A Novel IL-17 Inhibitor, Based on The Results of Phase 1 Clinical Study in Healthy Volunteers

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 2016300
Aug 20161203
Sep 2016704
Oct 2016400
Nov 20161300
Dec 20161800
Jan 20171300
Feb 20171701
Mar 20172601
Apr 2017600
May 20171007
Jun 2017600
Jul 20172200
Aug 20173000
Sep 20177001
Oct 20172402
Nov 20173600
Dec 20173400
Jan 20188000
Feb 20183101
Mar 20184601
Apr 20186801
May 20189001
Jun 201810203
Jul 20186000
Aug 20186800
Sep 20182200
Oct 20183000
Nov 20184001
Dec 20182201
Jan 2019800
Feb 20191500
Mar 2019800
Apr 20191400
May 20192000
Jun 20191400
Jul 20192100
Aug 20193001
Sep 20191200
Oct 20191400
Nov 20191000
Dec 20191200
Jan 2020600
Feb 20201203
Mar 2020501
Apr 2020400
May 2020800
Jun 20202400
Jul 20202900
Aug 20201600
Sep 20203300
Oct 2020300
Nov 2020400
Dec 20201000
Jan 20211200
Feb 2021800
Mar 2021800
Apr 2021001
May 2021100
Sep 2021100
Oct 20211401
Nov 2021400
Dec 20213702
Jan 2022900
Feb 2022400
Mar 2022600
Apr 20221100
May 20221600
Jun 2022200
Jul 2022400
Aug 20221500
Sep 20221000
Oct 20221000
Nov 2022801
Dec 2022800
Jan 20231000
Feb 20231501
Mar 2023700
Apr 2023200
May 20231700
Jul 2023800
Aug 2023601
Sep 20232400
Oct 20231301
Nov 20231400
Dec 2023800
Jan 20245200
Feb 2024400
Mar 20241600
Total1726041